2020
DOI: 10.1016/j.carrev.2019.08.022
|View full text |Cite
|
Sign up to set email alerts
|

Excimer Laser in Percutaneous Coronary Intervention of Device Uncrossable Chronic Total and Functional Occlusions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
8
0
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 9 publications
1
8
0
2
Order By: Relevance
“…Minor complications were observed in one case in each group (patients with failure of balloon to cross and failure of balloon expansion in the context of CTO), but not due to use of the laser [23]. Similar data was presented by Mohandes et al in a study of six patients with chronic total (100%) and functional occlusion, successful dilatation using excimer laser were achieved in five of the six patients (83.3%) [24].…”
Section: Description Of the State Of Knowledgesupporting
confidence: 82%
“…Minor complications were observed in one case in each group (patients with failure of balloon to cross and failure of balloon expansion in the context of CTO), but not due to use of the laser [23]. Similar data was presented by Mohandes et al in a study of six patients with chronic total (100%) and functional occlusion, successful dilatation using excimer laser were achieved in five of the six patients (83.3%) [24].…”
Section: Description Of the State Of Knowledgesupporting
confidence: 82%
“…ELCA works by producing monochromatic light energy to cause heat and shock waves that lead to disruption of plaque and thrombus. The indications for its use include optimisation of under‐expanded stents, 1 reduction in myocardial infarction (MI) related thrombus burden, 2 prestent treatment of degenerative saphenous vein grafts, 3 chronic total occlusions (CTO) 4 and noncrossable or nondilatable lesions 5 …”
Section: Introductionmentioning
confidence: 99%
“…Laser atherectomy has several niche indications, including balloon uncrossable or undilatable lesions, chronic total occlusions, debulking vein graft disease, and treating calcific non-dilatable ISR [ 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 ]. The Laser Veterans Affairs (LAVA) Multicenter Registry evaluated the use of ELCA in 130 target complex coronary lesions performed between 2008 and 2016 [ 92 ].…”
Section: Modalities For Coronary Calcium Modificationmentioning
confidence: 99%